| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | |||||||||||||
- | 10,412 | - | 9,784 | - | 683 | -5,331 | 1,851 | 3,031 | 448 | 233 | 1,353 | 1,641 | 422 |
Sales related party | |||||||||||||
- | 0 | - | 0 | - | 0 | -1,199 | 1,350 | 54 | 254 | 948 | 514 | 268 | 0 |
Total gross sales | |||||||||||||
9,703 | 10,412 | 9,859 | 9,784 | 7,752 | 683 | -6,531 | 3,201 | 3,086 | 703 | 1,182 | 1,867 | 1,909 | 422 |
Allowances | |||||||||||||
-304 | -264 | -354 | -1,739 | -2,115 | -218 | 23 | -2 | -5 | -15 | - | -80 | - | - |
Net sales | |||||||||||||
- | 10,148 | - | 8,044 | - | 465 | -5,308 | 1,848 | 3,026 | 433 | - | 1,273 | - | - |
Net sales related party | |||||||||||||
- | 0 | - | 0 | - | 0 | - | 1,350 | 54 | 254 | - | 514 | - | - |
Allowances | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | -501 | -222 |
Net Sales | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 1,139 | 199 |
Net sales related party | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 268 | 0 |
Total net sales | |||||||||||||
9,399 | 10,148 | 9,504 | 8,044 | 5,636 | 465 | -6,508 | 3,198 | 3,080 | 687 | 1,079 | 1,787 | 1,408 | 199 |
Costs of sales | |||||||||||||
2,732 | 3,700 | 4,097 | 2,959 | 1,914 | 165 | -1,754 | 1,106 | 523 | 228 | 532 | 261 | 398 | 162 |
Gross profit | |||||||||||||
6,666 | 6,447 | 5,407 | 5,085 | 3,721 | 300 | -4,753 | 2,091 | 2,557 | 459 | 546 | 1,525 | 1,010 | 37 |
Operating expenses excluding impairment losses | |||||||||||||
- | - | - | 11,230 | - | - | - | 1,464 | - | - | - | - | - | - |
Impairment of intangible assets | |||||||||||||
- | - | - | 2,114 | - | - | - | 0 | - | - | - | - | - | - |
Operating expenses | |||||||||||||
12,267 | 12,560 | 8,825 | 13,345 | 5,749 | 1,391 | -1,936 | 1,464 | 937 | 1,687 | 822 | 853 | 1,082 | 600 |
Debt conversion expense | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | -446 | - | - |
Other than temporary impairment on marketable securities | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | -175 | - | - |
Gain (loss) on disposal of property and equipment | |||||||||||||
- | - | - | 0 | - | - | - | 0 | 0 | -69 | - | 0 | 0 | 0 |
Interest income (expense) | |||||||||||||
- | - | - | -14 | - | - | - | 0 | 0 | 0 | 264 | 229 | 138 | -132 |
Income (loss) from operations | |||||||||||||
-5,600 | -6,112 | 18,613 | -30,290 | -2,027 | -1,091 | -2,746 | 627 | 1,619 | -1,297 | -275 | -178 | -211 | -695 |
Unrealized loss on marketable securities | |||||||||||||
- | - | - | - | - | - | - | - | - | 0 | - | - | - | - |
Realized and unrealized gain (loss) on marketable securities | |||||||||||||
-53 | -62 | - | -497 | 9 | 0 | - | 0 | 0 | 0 | - | - | - | - |
Impairment on investment other securities | |||||||||||||
600 | - | - | - | 0 | - | - | - | - | - | - | - | - | - |
Impairment accounts receivable other | |||||||||||||
160 | - | - | - | 0 | - | - | - | - | - | - | - | - | - |
(Increase) decrease on contingent liability | |||||||||||||
-21,261 | -16,898 | -20,000 | 21,547 | 30,914 | 0 | - | 0 | 0 | - | - | - | - | - |
Interest income | |||||||||||||
35 | 7 | - | - | 6 | 37 | - | - | - | - | - | - | - | - |
Income (loss) before provision for income taxes | |||||||||||||
14,883 | 10,730 | - | - | -32,925 | -1,053 | - | - | - | - | - | - | - | - |
Benefit for income taxes | |||||||||||||
0 | -2,240 | -63 | -1,088 | -1,075 | -133 | -6 | 62 | -23 | -33 | -17 | -36 | 76 | 2 |
Net income (loss) from continuing operations | |||||||||||||
14,883 | 12,970 | -4,397 | -8,260 | -31,850 | -920 | -2,816 | 627 | 1,619 | -1,228 | -275 | 671 | -72 | -563 |
Net loss from discontinued operations, net of tax (Note 15) | |||||||||||||
0 | -41 | - | - | 0 | -1,268 | - | - | - | - | - | - | - | - |
Net income (loss) | |||||||||||||
14,883 | 12,929 | 11,884 | -29,202 | -31,850 | -2,189 | -880 | 565 | 1,642 | -1,264 | -258 | -141 | -288 | -697 |
Net loss attributable to non-controlling interest | |||||||||||||
0 | 0 | - | - | -58 | -79 | - | - | - | - | - | - | - | - |
Preferred dividends | |||||||||||||
100 | 66 | - | - | 0 | 0 | - | - | - | - | - | - | - | - |
Net loss attributable to non-controlling interest | |||||||||||||
- | - | - | 1,503 | - | - | - | -359 | -238 | 131 | 79 | 68 | 267 | -63 |
Net income (loss) attributable to cbdMD, Inc. common shareholders | |||||||||||||
14,783 | 12,863 | 11,172 | -27,699 | -31,791 | -2,109 | -889 | 206 | 1,404 | -1,132 | -338 | -210 | -555 | -634 |
Net income (loss) per share: | |||||||||||||
Basic earnings per share | |||||||||||||
0.41 | 0.46 | 1.71 | -1.19 | -3.13 | -0.21 | - | 0.03 | 0.17 | - | - | -0.04 | -0.13 | - |
Diluted earnings per share | |||||||||||||
0.40 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.03 | 0.17 | - | - | 0.00 | -0.13 | - |
Weighted average number of shares - basic | |||||||||||||
36,503 | 27,720 | 28,141 | 23,193 | 10,160 | 10,052 | - | 8,075 | 8,025 | - | - | 4,686 | 4,217 | - |
Weighted average number of shares - diluted | |||||||||||||
37,336 | 28,553 | 51,335 | 0 | 10,160 | 10,052 | - | 8,092 | 8,040 | - | - | 0 | 0 | - |
Loss per share, basic and diluted | |||||||||||||
- | - | - | - | - | - | - | - | - | -0.16 | - | - | - | -0.18 |
Weighted average number of shares outstanding | |||||||||||||
- | - | - | - | - | - | - | - | - | 6,911 | - | - | - | 3,485 |